Fundamentals

Valuation

Metric	Q4	Q1	Δ in %
EV/EBITDA	153.16	74.89	29.58
Graham Fair Price	586.93	2.61	0.38
PEG	-99.96	< 0.005	-10.53
Price/Book	-14.94	0.65	0.77
Price/Cash Flow	9.56	-5.08	4.64
Prices/Earnings	-98.10	19.80	1039.95
Price/Sales	54.53	2.32	1.50
Price/FCF	9.56	-5.08	4.64
Naive Interpretation	member

01 - Valuation · Positive

Fundamentals

Profitability

Metric	Q4	Q1	Δ in %
Gross Profit Margin	50.35	0.13	0.09
Operating Margin	16688.66	0.03	< 0.005
ROA	4755.96	< 0.005	< 0.005
ROE	< 0.005	< 0.005	4367.48
ROIC	< 0.005	< 0.005	1030.02
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q4	Q1	Δ in %
Debt QOQ	-0.09	-0.04	-138.64
Dividends QOQ	-0.40	-0.24	41.15
EBIT QOQ	-0.99	91.00	9046.14
EPS QOQ	-0.99	44.45	4399.67
FCF QOQ	316.83	-1.77	-99.44
Revenue QOQ	0.29	-0.45	55.58
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q4	Q1	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	61.72	131.55	113.15
Days Sales Outstanding (DSO)	269.86	461.71	71.09
Inventory Turnover	1.46	0.68	-53.09
Debt/Capitalization	0.18	0.17	-7.33
Quick Ratio	1.05	1.03	-2.20
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q4	Q1	Δ in %
Book Value	5.89	6.05	2.77
Cash	2.48	1.38	-44.23
Capex	< 0.005	< 0.005	149.97
Free Cash Flow	0.98	-0.78	-20.21
Revenue	3.02	1.71	-43.43
Naive Interpretation	member

05 - Per Share Metrics · Bad

Fundamentals

Financial Health

Metric	Q4	Q1	Δ in %
Current Ratio	1.28	1.33	3.51
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	-10.60	-3.56	66.44
Naive Interpretation	Member

06 - Financial Health · Weak

Rating